Considering that serum sclerostin was positively associated with bone formation marker(PINP) and negatively associated with MACCEs and surrogate markers of CAD severity (including CCS angina class and presence of multivessel disease) in our study, sclerostin may be speculated to mediate the bone–vascular axis. The gene discussed is SOST; the disease is coronary artery disorder.